The curtain rises on Rocket Lab USA’s second-quarter results Monday after the closing bell, with the conference call scheduled for 5:00 p.m. Eastern Time. Wall Street’s consensus points to revenue of roughly $231.6 million — a year-over-year jump of about 60 percent — though the range of estimates has drifted slightly, with some analysts pegging the figure closer to $230.95 million. Either way, the numbers would mark a continuation of the growth trajectory that saw the company post a 63.5 percent revenue surge to $200.3 million in a prior quarter.
Investors have already cast their vote of confidence. The stock closed Friday at $82.83, up 9.46 percent on the day, though that still leaves the shares roughly 45 percent below the May record high of $151.00. Year to date, the equity has gained 18.74 percent.
A Contract Pipeline That Keeps Growing
The pre-earnings optimism isn’t凭空 — it’s anchored in a flurry of recent deal announcements. On August 4, Rocket Lab disclosed a $397 million award from the US Space Force for the Space-Based Airborne Moving Target Indicator program, covering development, launch, and operation of multiple Flatellite satellites aboard the Neutron rocket, with additional Flatellites already priced in as options. Just over a week earlier, on July 27, the Space Force had handed the company a $266 million contract for suborbital missile-defense launches — described by Rocket Lab as the largest missile-defense agreement in its history. That deal reportedly encompasses 12 suborbital missions.
The commercial side has been equally active. On July 30, Rocket Lab inked another multi-launch agreement with Japanese Earth-observation firm iQPS, covering three additional Electron missions — the third such arrangement within a year. Days later, on August 6, the company completed its 92nd Electron launch, the eighth flight for the iQPS constellation, delivering the QPS-SAR-13 satellite to orbit. Rocket Lab’s success rate on iQPS missions stands at a perfect 100 percent, with ten more booked launches expected to complete the constellation by 2030.
The cumulative effect: a backlog now estimated at over $2.2 billion.
The Iridium Deal Grinds Through Approvals
Alongside the operational wins, the proposed acquisition of Iridium Communications — announced in June — continues its slow march through regulatory channels. The transaction values Iridium at roughly $8.0 billion, with shareholders receiving $54 per share in a mix of $27 cash plus Rocket Lab stock. A $3.6 billion bridge financing facility is in place to support the deal. On August 6, Iridium filed a question-and-answer form with the SEC for its workforce regarding the takeover — a signal that the proxy and consent process is moving forward. Completion is targeted for mid-2027, subject to Iridium shareholder approval and regulatory sign-offs.
What the Numbers Should Show
Management’s own guidance from early May projected second-quarter revenue between $225 million and $240 million, with GAAP gross margin of 33 to 35 percent and adjusted gross margin of 38 to 40 percent. Operating expenses were expected to land between $138 million and $144 million, with an adjusted EBITDA loss of $20 million to $26 million. The consensus earnings estimate calls for a loss of $0.06 per share. Whether the company lands within those ranges — or, as the consensus suggests, edges above them — will be the immediate question when the numbers hit the tape.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Investors will also be listening for updates on the Neutron rocket’s debut, still slated for late 2026. The larger launch vehicle is central to Rocket Lab’s ambitions to carry heavier payloads and compete more directly with bigger industry players.
The Insider Selling Counterweight
There’s a wrinkle in the otherwise bullish narrative. Over the past 90 days, insiders have sold Rocket Lab shares worth approximately $896 million, according to data service InsiderScreener, with CEO Peter Beck the primary seller through planned trading programs. One notable transaction: Beck disposed of 990,960 shares on July 8 at $82.86 per share.
The selling comes against a backdrop of volatility — shares previously tumbled 22.3 percent following an earlier quarterly report. For investors weighing today’s results, it’s a reminder that while the operational momentum is undeniable, those closest to the company have recently been more measured in their conviction than the share price might suggest.
Institutional Support and Analyst Sentiment
Offsetting the insider activity is a notable buildup among institutional holders. Hennion & Walsh Asset Management increased its stake by 11.6 percent to 93,586 shares, valued at roughly $9.5 million. PensionDanmark made an even more aggressive move, boosting its position by over 224 percent to approximately 41,000 shares. Institutional investors now control nearly 72 percent of the company’s stock.
The analyst community remains broadly constructive, with a consensus rating of “Strong Buy” drawn from 13 buy recommendations and 4 holds. The average price target sits at $110.53, implying substantial upside from current levels.
Monday’s session also brings earnings from competitor AST SpaceMobile, which could inject additional volatility into the space sector as a whole. For Rocket Lab, the question is whether a strong print and fresh Neutron commentary can sustain the momentum — and whether the insider selling pattern gives investors any pause.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from August 10 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 10.
Rocket Lab USA: Buy or sell? Read more here...
